Optic Pathway Glioma - 25 Studies Found
Completed |
: Antineoplaston Therapy in Treating Children With Visual Pathway Glioma : Visual Pathway Glioma : 1999-11-01 : Drug: Antineoplaston therapy (Atengenal + Astugenal) Children with a visual pathway glioma, which is not |
Recruiting |
: Phase II Pegylated Interferon :
: Drug: Pegylated interferon alpha-2b PEG-Intron 1mcg/kg/dose weekly through an injection under the skin o |
Active, not recruiting |
: Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma :
|
Active, not recruiting |
: Ophthalmological Screening and Follow-up of Optic Pathway Gliomas in Children With Neurofibromatosis Type 1. : Neurofibromatosis Type 1 : 2014-02-26 |
Withdrawn |
: Phase 3 Study of ANP Therapy vs. TMZ for Optic Pathway Glioma : Optic Nerve Glioma : 2010-12-13 :
|
Terminated |
: Sorafenib in Children and Young Adults With Recurrent or Progressive Low-Grade Astrocytomas :
|
Recruiting |
: Hypotonia and Neurofibromatosis Type 1 (NF1) Glioma : Neurofibromatosis Type 1 : 2015-10-20 :
|
Recruiting |
: Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma :
|
Active, not recruiting |
: Pomalidomide in Treating Younger Patients With Recurrent, Progressive or Refractory Central Nervous System Tumors :
|
Withdrawn |
: Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors :
|